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Human immunodeficiency virus (HIV) antiretroviral agents and effective HIV care management transformed
HIV disease from a death sentence to a chronic condition for many in the United States. A comprehensive HIV
care model was developed to meet the complex needs of HIV patients, with support from the Ryan White
program, the Veterans Administration, and others. This paper identifies the essential components of an
effective HIV care model. As access to health care expands under the National HIV/AIDS Strategy and the
Patient Protection and Affordable Care Act, it will be critical to build upon the HIV care model to realize
positive health outcomes for people with HIV infection.
THE EVOLUTION OF HIV CARE
Antiretroviral therapy and expert human immunodefi-
ciency virus (HIV) care management transformed HIV
disease from a death sentence to a chronic condition for
many in the United States, as evidenced by the near-
normal life spans expected for most HIV patients
today [1]. The complexity of treatment and manage-
ment of this multiorgan system disease requires co-
ordination among many providers in outpatient and
inpatient settings. The comprehensive HIV care model
was developed to address the challenges providers face
in meeting the complex medical and psychosocial needs
of many HIV-infected patients [2]. The model has been
critical to the success of HIV treatment in dramatically
reducing HIV morbidity and mortality rates by as
much as 80% [3]. In the HIV Prevention Trials Net-
work 052 study, antiretroviral therapy was associated
with a 96% reduction in sexual transmission to HIV-
negative partners and with improved health outcomes
for the HIV-infected patient. In light of these results, we
anticipate an even greater emphasis on identifying and
linking people with HIV to care, which will require
greater system capacity and increased emphasis on ef-
fective HIV care models [4].
The Ryan White program is one example of an ef-
fective HIV care model. Created by the US Congress in
1990 to help communities respond to the HIV epidemic,
the program grants HIV clinics the flexibility to develop
systems of care that are responsive to the needs of local
patient populations [5]. The program is the third largest
funder of HIV care in the United States, after Medicare
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and Medicaid, and provides grants to states, high-impact cities,
and clinical programs [6]. It has supported the development of
centers of excellence in HIV care across the United States.
The president’s National HIV/AIDS Strategy (NHAS) sets
a framework for leveraging federal and private resources to re-
duce HIV incidence, increase access to care, improve health
outcomes, and reduce HIV-related disparities [7]. The Patient
Protection and Affordable Care Act (ACA) together with the
NHAS provides an unprecedented opportunity to improve ac-
cess to HIV care and develop more sustainable funding streams
that can be used to expand access to the effective HIV caremodel
developed by the Ryan White program [8, 9]. To do so will
require Medicaid, Medicare, and private insurers to adopt de-
livery systems and risk-adjusted payment mechanisms that
support access to effective HIV care. This paper outlines the
essential components of an effective HIV care model (Figure). It
will be critical to build on this effective model for chronic disease
management to promote positive health outcomes for people
with HIV infection, particularly those with more intense medical
and social service needs, as they gain health insurance coverage
under the ACA.
GOALS OF HIV CARE
Effective HIV care leads to earlier and greater engagement in care,
effective viral control, improved immune status, near-normal
life expectancy, enhanced quality of life, and prevention of HIV
transmission [4, 10]. These goals can be achieved through
increased HIV testing within communities, efficient linkage to
HIV primary continuity care and specialty care, access to HIV
medications, medication adherence support, efforts to retain
patients in care, and social services that address the unmet
psychosocial needs of HIV-infected patients [11, 12]. However,
if these essential aspects of effective care are fragmented, that is,
not integrated, patients receive either incomplete care or no
care at all. The NHAS estimates that 35% of patients newly
diagnosed with HIV are not linked to HIV care within
3 months of diagnosis, which is recommended by the Centers
for Disease Control and Prevention. However, higher levels of
linkage are found in integrated care systems [7, 13]. Previous
reports estimated that between 30% and 50% of HIV patients
are not in ongoing care and do not have reliable access to HIV
treatment. Ryan White clinical programs report that 73% of
patients are in continuous care, defined as at least 2 visits,
3 months apart, within 1 year [7, 14–16]. Stigma and health
disparities also lead to inconsistent care [1, 17]. Delayed entry
into care and cycling in and out of care can lead to poor clinical
outcomes, development of drug-resistant virus, and trans-
mission of HIV to others [18].
As the goals of HIV care suggest, integrated medical care for
HIV-infected patients is essential. In general, this has been
achieved through the ‘‘medical home’’ model. In this model,
access to primary and specialty care is coordinated and moni-
tored by the HIV primary care team, as are psychosocial and
social services for patients based on their needs. HIV providers
have subscribed to this model of care since the early 1990s, with
Figure. Essential components of HIV care. Abbreviation: HIV, human immunodeficiency virus.
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Ryan White Part C clinics, Veterans Administration (VA), and
other health care systems as strong examples [19–21]. The high
rates of care and treatment adherence required for ongoing
suppression of HIV are best supported within this type of in-
tegrated service delivery environments, such as Ryan White–
funded clinics and the VA [22]. This is particularly true for
patients with 2 or more co-occurring conditions.
The extent and type of care integration vary according to the
complexity and needs of a clinic’s HIV patient population. The
simplest category of collaborative services is coordinated care
that is delivered in different settings but with information
sharing among the programs. Colocated (services delivered at
one location, with data sharing) and integrated (merged medical
and behavioral health care components, including mental health
and substance use treatment in one treatment plan) medical
services are used for patients with complex needs to prevent
barriers or gaps in service delivery. Electronic health records
(EHRs) that can be shared by the entire care team, specialists,
and others who provide the patient’s care are a key component
of the integrated care model.
Lower levels of integration can be sufficient for the care of
some HIV patients. Critical system components for all levels of
integration include established relationships with providers and
ongoing communication between the HIV primary care team or
the HIV expert and other specialty, primary care, mental, and
social service providers. Effective HIV programs allow for a tai-
lored approach for a service population and an individualized
approach for patients, using a variety of methods to meet a
broad range of needs.
ELEMENTS OF CARE DELIVERY
Care Team
The HIV care team includes an HIV expert who manages or
comanages the patient’s HIV primary continuity care needs and
identifies subspecialty care needs. A care coordinator, who may
be a qualified nurse, case manager, or another member of the
care team, is responsible for maintaining communication and
coordination with other providers as well as identifying and
coordinating access to services such as psychosocial support,
reproductive and gynecologic services, alcohol or drug treat-
ment, drug assistance programs, prevention counseling, and
other services required to meet basic needs. Medication man-
agement is a critical component of primary HIV care, and ideally
a clinical pharmacist with HIV expertise is included on the team
to identify drug interactions, support patient adherence and
medication management, and oversee medication profiles for
patients who see multiple medical providers [23–26].
A range of other specialists also participate on the HIV care
team to treat the comorbidities common among HIV patients,
such as hepatitis B and C, HIV-related and nonrelated
malignancies, heart disease, metabolic disorders, serious mental
illnesses, and substance use disorders, and tomeet needs of unique
populations, such as women requiring obstetric-gynecological
care [27–32]. Subspecialists ideally have an ongoing relationship
with the HIV care team and have the appropriate level of
comfort and expertise with HIV disease. Mental health and
substance use treatment services, including psychiatric care and
psychotherapy, are particularly important given that as many as
50% of HIV patients also have a psychiatric diagnosis and/or
a substance use disorder [33]. Dental and oral health care is
recognized as an important component of comprehensive HIV
care, and access to oral health providers with HIV experience is
preferred [34].
HIV Medical Provider Expertise
Patients with HIV disease who are managed by clinicians with
greater HIV experience and expertise have better health out-
comes and receive more appropriate and cost-effective care,
regardless of the clinician’s specialty training [35–38]. HIV
disease does not fall under the purview of any one medical
specialty—physicians trained in internal medicine, family med-
icine, and other medical subspecialties join infectious disease
specialists as HIV experts. Although many HIV experts are in-
fectious disease physicians, not all infectious disease physicians
are HIV experts. Ongoing patient management and continuing
education are required for HIV expertise, regardless of specialty
training.
The primary care and specialty boards do not recognize an
HIV specialty designation. The HIV Medicine Association
(HIVMA) developed guidance in 2002, updated in 2010, to
assist third-party payers, health systems, and institutions in
identifying HIV physicians who are qualified to provide HIV
care. HIVMA recommends a combination of patient manage-
ment experience and continuing medical education to identify
qualified HIV physicians. (HIVMA recommends that HIV
physicians have managed a minimum of 25 patients with HIV
during the previous 36 months and have completed a minimum
of 40 hours of category 1 HIV-related continuing medical ed-
ucation during the same period. HIVMA also recommends that
infectious disease physicians certified or recertified within the
previous 12 months be considered qualified HIV physicians. In
the 36 months immediately following certification, newly cer-
tified infectious diseases fellows should be managing a mini-
mum of 25 patients with HIV and earning a minimum of 10
hours of category 1 HIV-related continuing medical education
per year.) The American Academy of HIV Medicine (AAHIVM)
has a credentialing process for HIV physicians, nurse practi-
tioners, physician’s assistants, and pharmacists. The Associa-
tion of Nurses in AIDS Care created the HIV/AIDS Nursing
Certification Board for certification of registered nurses and
nurse practitioners in HIV nursing [39]. Some states, including
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California, have adopted the HIVMA and AAHIVM recom-
mendations for identifying HIV experts, while other states,
including Arizona, have developed their own definition using
similar criteria [40, 41].
Caseloads and appointment times vary greatly according to
provider expertise, disease severity, and comorbidities. Clinic
staffing levels and available resources also affect the number of
patients that providers can effectively manage. Evolving pro-
ductivity standards that support quality care by HIV clinicians
should reflect the complexity and intensity of HIV care and
allow adequate time to monitor and manage the patient’s HIV
treatment and primary care needs and provide oversight of
comorbidity management.
Access to an HIV Expert
The specialized expertise required of HIV clinicians contributes
to a growing shortage of HIV medical providers and necessitates
models for managing HIV care that can be adapted to the re-
sources available in a community [42]. Under the Ryan White
care model, HIV-infected patients typically have a medical
provider who manages their HIV and primary care or an on-site
medical team that includes an HIV expert who comanages pa-
tients with a primary care provider.
For healthier patients with less intensive medical and social
service needs, a comanagement model in which a primary care
provider has an ongoing consultative relationship with an HIV
expert is also effective, particularly when the provider relation-
ship is established at the time of the patient’s HIV diagnosis. In
this model, the patient has a primary care provider who consults
with the HIV expert. The HIV expert manages the patient’s
HIV treatment through regular visits, typically at intervals of
3 to 6 months.
In settings with a dearth of HIV experts, a primary care
provider may manage the ongoing care of the patient, with the
HIV expert serving as an ongoing consultant via teleconference
or telemedicine [43].
Regardless of the role of the HIV expert, the patient and
medical provider relationship has proven to be central to ef-
fective primary care and chronic disease management [44, 45].
An ongoing and consistent relationship between patient and
provider establishes open communication and trust. HIV pa-
tients who trust their medical providers have better medication
adherence rates and are more likely to accept treatment rec-
ommendations [46–48].
Quality Improvement
Quality improvement is an integral component of the HIV care
model and a requirement of Ryan White funding [34]. Other
integrated health systems have identified the value of such efforts
[13, 49]. Programs collect quality and outcomes measures and
utilize the data to evaluate and monitor clinical processes and
patient outcomes and to effectively manage limited program
resources. Prevention, care, and treatment guidelines developed
by the US Department of Health and Human Services and
professional associations inform the scope and content of HIV
provider practices (Table 1). Corresponding quality measures
are employed to evaluate provider and practice adherence to
standards of HIV care. Evaluations utilizing these measures are
performed by the practice itself (internal quality management)
and by funding agencies (external quality assurance) to ensure
Table 1. HIV Prevention and Treatment Guidelines and
Recommendations
Federal HIV-related guidelines and recommendations, including date
of implementationa
Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected
Adults and Adolescents—10 January 2011
Guidelines for the Use of Antiretroviral Agents in Pediatric HIV
Infection—16 August 2010
Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-
Infected Women for Maternal Health and Interventions to Reduce
Perinatal HIV Transmission in the United States—24 May 2010
MMWR: Updated US Public Health Service Guidelines for the
Management of Occupational Exposures to HIV and Recom-
mendations for Postexposure Prophylaxis—30 September 2005
MMWR: Antiretroviral Postexposure Prophylaxis After Sexual,
Injection-Drug Use, or Other Nonoccupational Exposure to HIV in
the United States—21 January 2005
Guidelines for Prevention and Treatment of Opportunistic Infections
in HIV-Infected Adults and Adolescents—10 April 2009
MMWR: Guidelines for the Prevention and Treatment of
Opportunistic Infections Among HIV-Exposed and HIV-Infected
Children—4 September 2009
Incorporating HIV Prevention Into the Medical Care of Persons Living
With HIV—18 July 2003
MMWR: Revised Recommendations for HIV Testing of Adults,
Adolescents, and Pregnant Women in Health-Care Settings—22
September 2006
Guidelines Developed by the HIV Medicine Association of the In-
fectious Diseases Society of Americab
Primary Care Guidelines for the Management of Persons Infected
with Human Immunodeficiency Virus: 2009 Update by the HIV
Medicine Association of the Infectious Diseases Society of
Americac
Guidelines for the Management of Chronic Kidney Disease in
HIV-Infected Patients: Recommendations of the HIV Medicine
Association of the Infectious Diseases Society of Americad
Guidelines for the Evaluation and Management of Dyslipidemia in
Human Immunodeficiency Virus (HIV)–Infected Adults Receiving
Antiretroviral Therapye
Guidelines Developed by the International Antiviral Society-USAf
Antiretroviral Treatment of Adult HIV Infectiong
Abbreviations: HIV, human immunodeficiency virus; MMWR, Morbidity and
Mortality Weekly Report.
a Available at http://www.aidsinfo.nih.gov/Guidelines/Default.aspx.
b Available at http://www.hivma.org.
c Clinical Infectious Diseases 2009; 49:651–81.
d Clinical Infectious Diseases 2005; 40:1559–85.
e Clinical Infectious Diseases 2003; 37:613–27.
f Available at http://www.iasusa.org/guidelines/.
g JAMA 2010; 304:321–33.
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that patients are offered a uniform standard of care, regardless
of location. This is particularly important in areas where HIV
expertise may be lacking. In these areas, quality measurement
can support workforce development by enhancing HIV knowl-
edge and expertise among willing but inexperienced providers.
Rapid advances in HIV medicine make quality management
and clinical practice tools, such as practice guidelines, critical to
supporting and evaluating implementation of the latest stand-
ards of care. HIV-related quality measures developed by a con-
sortium with the National Committee for Quality Assurance
have been endorsed by the National Quality Forum and in-
corporated into Medicare’s Physician Quality Reporting Sys-
tem (PQRS) [50]. Adoption of uniform measures across federal
programs and by private insurers is important when evaluating
and improving HIV care outcomes, regardless of insurance status
or funding source (Table 2).
The HIVQual program developed by the New York AIDS
Institute and the HIV/AIDS Bureau has assisted Ryan White–
funded clinics with building sophisticated quality management
systems. Participating programs use quality improvement and
performancemeasures to improve their delivery ofHIV care [51].
The PQRS, developed by the Centers for Medicare and Med-
icaid Services (CMS), provides incentive payments to providers
for reporting on certain HIV-related quality measures. Reporting
of HIV measures is currently limited to registries; this creates
administrative barriers to participation for some programs,
limiting the potential for the PQRS to improve HIV care [52].
Electronic Health Records
EHRs are a key component of effective integrated care and
medical home models. Although HIV programs are at varying
levels of EHR implementation, HIV care programs, including
many funded by the Ryan White program, have been leaders in
using EHRs and/or electronic data collection to support quality
improvement programs and to meet data reporting require-
ments. Many commercial products can meet these needs, and
some health care systems and clinics have developed their
own (examples include the VA and the University of Alabama
at Birmingham [UAB] 1917 Clinic). A majority of Ryan White–
funded medical programs utilize CAREWare, software de-
veloped by the HIV/AIDS Bureau in 2000 that is used to monitor
clinical and supportive care (http://hab.hrsa.gov/careware/).

















Retention in care U . 0403 U U
CD4 cell count U 159 0404 . U
Gonorrhea/chlamydia screening U 205 0409 . U
Syphilis screening U 208 0410 . U
Injection drug use screening U 207 0415 . Substance use screening
High-risk sex screening U 206 0413 . HIV risk counseling
Tuberculosis screening U . 0408 . U
Hepatitis B screening U . 0411 . U
Hepatitis C screening U . 0414 . U
Influenza immunization U . 0522 . U
Pneumococcal immunization U . 0525 . U
Hepatitis B vaccination order U . 0412 . U
Hepatitis B vaccination completed U . . . .
PCP prophylaxis U 160 0405 . U
Adolescents/adults prescribed ART U 161 0406 . U
Achieving maximal viral control
(system level)
U . . . .
Achieving maximal viral control
(provider level)
U 162 0407 . .
Abbreviations: ART, antiretroviral therapy; HAB, HIV/AIDS Bureau; HHS, US Department of Health and Human Services; HIV, human immunodeficiency virus;
HIVMA, HIV Medicine Association; HRSA, Health Resources and Services Administration; NCQA, National Committee for Quality Assurance; NQF, National Quality
Forum; PCP, Pneumocystis pneumonia; PQRS, Physician Quality Reporting System.
a Horberg et al, Development of National and Multiagency HIV Care Quality Measures, CID 2010; 51:732–38.
b Measure included and assigned a number in CMS’ 2011 Physician Quality Reporting System Individual Quality Measures, http://www.cms.gov/PQRI/
15_MeasuresCodes.asp.
c National Quality Forum–endorsed standards can be accessed at: http://www.qualityforum.org/Measures_List.aspx.
d Health Resources and Services Administration. HIV/AIDS Bureau. HIV Performance Measures, http://hab.hrsa.gov/deliverhivaidscare/habperformmeasures.html.
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TheMedicare andMedicaid EHR Incentive Programs provide
financial incentives for providers to adopt and use EHRs and
require providers to report on CMS-identified quality measures.
HIV-specific measures were not included in stage 1 of the
clinical quality measures. The addition of HIV measures during
the next phase will be important to improve the delivery of care,
align HIV program expectations across federal agencies, and
monitor progress toward the goals of the NHAS [53].
Sustainability
Financial viability is a component of effective HIV care delivery
and is important to supporting access to expert HIV providers
and programs. The financial operating requirements for the
delivery of effective HIV care are complex, with many programs
relying on institutional support to cover salaries, administrative
infrastructure, rent, and other operating costs. However, in the
current environment, models of care with costs that exceed
benefits to the institutions are no longer sustainable.
Effective payment systems and methodologies are grounded
in the cost of care, adjusted according to disease severity, and
take into account nonclinical costs associated with chronic
disease management, such as care coordination, quality moni-
toring and evaluation, and EHR adoption.With a few exceptions,
most state Medicaid programs fall short in supporting com-
plex, comprehensive HIV care. The new Medicaid health home
benefit, for which HIV disease is identified as an eligible con-
dition, provides an important opportunity for states to support
this level of care [54]. The movement toward health home or
medical home care provides an opportunity to transform the
delivery of chronic care if supported through innovative and
reasonable provider payment mechanisms.
Fee-for-Service
The Medicaid and Medicare programs cover 40% and 20%,
respectively, of people with HIV in care [6]. The inadequacy of
payment rates under both programs contributes to health-
related disparities in access and outcomes [55–57]. Medicaid
rates average 66% of Medicare payment rates for primary care
services, yet even Medicare rates fall short of supporting the true
cost of care. In a study conducted by the 1917 Clinic at UAB,
Medicare payments for physician services for patients with HIV
disease averaged $359 per year, with a range of $285 to $533 per
patient per year, depending on disease severity [58]. The annual
payment covers 18% of the $1959 in per-patient medical pro-
vider costs incurred by the UAB 1917 Clinic for managing the
patient’s primary and HIV care needs (James Raper, DSN,
CRNP, JD, personal communication, January 2011).
Managed Care Capitation Rates
Under managed care, adequate monthly capitation rates are
grounded in the cost of care and are risk-adjusted according to
disease severity to ensure that quality and outcomes are not
compromised due to cost [59]. A few states have developed
payment mechanisms under Medicaid managed care to support
HIV care. For example, the Maryland Medicaid program pays
special capitation rates for Medicaid beneficiaries with HIV and
AIDS that are adjusted for geography and hepatitis C status.
Services with unpredictable costs are excluded and paid on a fee-
for-service basis, including HIV antiretroviral agents, viral load,
and HIV drug resistance testing (Table 3). In 2003, the New
York State Department of Health’s AIDS Institute established
3 managed care plans, referred to as HIV Special Needs Plans
(SNPs), in New York City for Medicaid beneficiaries with HIV
disease [60]. SNPs are paid capitation rates that exclude all
pharmaceuticals, including antiretroviral medications; the rates
are based on the enrollee’s age and receipt of supplemental se-
curity income (Table 4). Beginning in October 2011, New York
state plans to incorporate pharmaceuticals and other services
previously paid on a fee-for-service basis into the managed care
benefit package for HIV SNPs and other Medicaid managed
care plans and to adjust the capitation rates accordingly.
Public Health Funding
Appropriated by the federal government with contributions
from state governments, RyanWhite funding has allowed for the
development of a robust system of care for people with HIV who
are uninsured (nearly 30% of those diagnosed and living with
HIV) or underinsured and at serious risk for going untreated in
the absence of Ryan White–funded services [61]. Given the in-
adequacies of third-party coverage and payments, Ryan White
Table 3. MarylandMedicaidMonthly Capitation Rates, 1 January
2011–31 December 2011
City of Baltimore Rest of state
Disabled persons with AIDS $3030.41 $2135.18
Disabled persons with HIV $1609.69 $1609.69
Families and children with HIV $612.79 $612.79
Source: Maryland Office of the Secretary of State. COMAR (codification
number 10.09.65.19). Available at: http://www.dsd.state.md.us/comar/.
Abbreviation: HIV, human immunodeficiency virus.
Table 4. New York HIV Medicaid Managed Care Monthly
Capitation Rates, March 2010–April 2011a





Source: New York State Department of Health AIDS Institute, August 2011.
Abbreviations: HIV, human immunodeficiency virus; SSI, supplemental
security income; TANF, temporary assistance for needy families.
a These rates will be adjusted in October 2011 to reflect costs for services such
as pharmaceuticals that were previously paid on a fee-for-service basis because
these services will be incorporated into the managed care benefit package.
b Under 21 years of age.
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funding will remain vital to ensuring access to HIV care and
treatment for individuals who remain uninsured or are un-
derinsured under the ACA.
CONCLUSION
The HIV care model that incorporates the best aspects of the
medical homemodel and contributes to our remarkable success in
treating HIV disease should be promoted and enhanced with
national health care reform. Further evaluation of this HIV care
model and its impact on patient outcomes and cost effectiveness is
warranted to inform the development of financing and delivery
systems that improve HIV care and care for other complex,
chronic conditions. The ACA, steered by the NHAS, offers great
promise for turning the tide of the HIV epidemic if it builds on the
remarkable delivery and care programs developed by the Ryan
White program and other HIV providers. However, Medicaid and
Medicare payment reform for complex care management along
with continuation of the public health funding available through
the Ryan White program will be critical to maintaining the HIV
care model. This reform and continued funding will also make
it possible to improve outcomes for people with HIV and
prevent HIV infection through effective HIV care. Weakening
of this model, with fragmentation of care or a decline in es-
sential services, will not only result in adverse consequences for
HIV-infected patients but will also increase preexisting dis-
parities in health outcomes and HIV transmission within at-
risk communities, ultimately increasing the burden of disease
and the cost of HIV care.
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